AR032036A1 - Tratamiento de tumores inoperables por medio de inyeccion estereotactica de microesferas - Google Patents
Tratamiento de tumores inoperables por medio de inyeccion estereotactica de microesferasInfo
- Publication number
- AR032036A1 AR032036A1 ARP010106009A ARP010106009A AR032036A1 AR 032036 A1 AR032036 A1 AR 032036A1 AR P010106009 A ARP010106009 A AR P010106009A AR P010106009 A ARP010106009 A AR P010106009A AR 032036 A1 AR032036 A1 AR 032036A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- microspheres
- stereotactic injection
- inoperable tumors
- tumor
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 4
- 239000004005 microsphere Substances 0.000 title abstract 3
- 238000002347 injection Methods 0.000 title abstract 2
- 239000007924 injection Substances 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epoxy Compounds (AREA)
Abstract
Uso de microesferas biodegradables que liberan un agente anticancerígeno, para la fabricacion de un medicamento para el uso en el tratamiento de tumores inoperables en seres humanos, en donde las microesferas biodegradables se administran por medio de inyeccion estereotáctica al tumor, al área peritumoral, o al mismo tiempo al tumor y al área peritumoral.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25716700P | 2000-12-22 | 2000-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR032036A1 true AR032036A1 (es) | 2003-10-22 |
Family
ID=22975167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010106009A AR032036A1 (es) | 2000-12-22 | 2001-12-21 | Tratamiento de tumores inoperables por medio de inyeccion estereotactica de microesferas |
Country Status (7)
Country | Link |
---|---|
US (2) | US20020081339A1 (es) |
EP (1) | EP1343477A2 (es) |
JP (1) | JP2004529865A (es) |
AR (1) | AR032036A1 (es) |
AU (1) | AU2002234798A1 (es) |
CA (1) | CA2432518A1 (es) |
WO (1) | WO2002051388A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020081339A1 (en) * | 2000-12-22 | 2002-06-27 | Philippe Menei | Treatment of inoperable tumors by stereotactic injection of microspheres |
WO2005018600A2 (en) * | 2003-08-22 | 2005-03-03 | Cube Medical A/S | Method of treating a patient suffering from a solid tumour |
CN1909920A (zh) * | 2004-03-18 | 2007-02-07 | 圣卢加医院 | 缓释剂的传送方法 |
EP1985286A1 (en) * | 2007-04-24 | 2008-10-29 | Biocompatibles UK Limited | Microspheres for treatment of brain tumours |
JP6921759B2 (ja) | 2015-06-04 | 2021-08-18 | クリティテック・インコーポレイテッド | 捕集装置および使用法 |
DK3439635T3 (da) | 2016-04-04 | 2021-03-08 | Crititech Inc | Formuleringer til behandling af fast tumor |
SG11201909840TA (en) | 2017-06-09 | 2019-11-28 | Crititech Inc | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
BR112019022720A2 (pt) | 2017-06-14 | 2020-05-12 | Crititech, Inc. | Métodos para tratar distúrbios pulmonares |
CN111278436A (zh) | 2017-10-03 | 2020-06-12 | 克里蒂泰克公司 | 局部递送抗肿瘤颗粒与全身递送免疫治疗剂相结合用于治疗癌症 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6537585B1 (en) * | 1999-03-26 | 2003-03-25 | Guilford Pharmaceuticals, Inc. | Methods and compositions for treating solid tumors |
FR2793684B1 (fr) * | 1999-05-17 | 2001-08-10 | Ethypharm Lab Prod Ethiques | Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant |
DE60030770T2 (de) * | 1999-12-06 | 2007-09-06 | Rhode Island Hospital | Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen |
US20020081339A1 (en) * | 2000-12-22 | 2002-06-27 | Philippe Menei | Treatment of inoperable tumors by stereotactic injection of microspheres |
-
2001
- 2001-12-20 US US10/022,241 patent/US20020081339A1/en not_active Abandoned
- 2001-12-21 CA CA002432518A patent/CA2432518A1/en not_active Abandoned
- 2001-12-21 AU AU2002234798A patent/AU2002234798A1/en not_active Abandoned
- 2001-12-21 AR ARP010106009A patent/AR032036A1/es not_active Application Discontinuation
- 2001-12-21 EP EP01985451A patent/EP1343477A2/en not_active Withdrawn
- 2001-12-21 WO PCT/IB2001/002810 patent/WO2002051388A2/en active Application Filing
- 2001-12-21 US US10/451,216 patent/US20040180095A1/en not_active Abandoned
- 2001-12-21 JP JP2002552534A patent/JP2004529865A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002051388A3 (en) | 2003-02-13 |
JP2004529865A (ja) | 2004-09-30 |
US20020081339A1 (en) | 2002-06-27 |
US20040180095A1 (en) | 2004-09-16 |
CA2432518A1 (en) | 2002-07-04 |
WO2002051388A2 (en) | 2002-07-04 |
AU2002234798A1 (en) | 2002-07-08 |
EP1343477A2 (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2557988T3 (es) | Método para tratar enfermedades de próstata basado en el suministro local de principios activos | |
AR027355A1 (es) | Acidos tiazolidincarboxilicos | |
ES2249888T3 (es) | Conjugados de paclitaxel solubles en agua, combinados con irradiacion para el tratamiento del cancer. | |
AR045179A1 (es) | Uso de una combinacion de un inhibidor de la quinasa del receptor del factor de crecimiento epidermico y de agentes citotoxicos para el tratamiento e inhibicion del cancer | |
BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
BR0102040A (pt) | Uso de paclitaxel estabilizado com albumina para preparação de uma droga para o tratamento de tumores sólidos e a droga desse modo obtida | |
BRPI0412975A (pt) | espuma penetrante para uso farmacêutico | |
BRPI0207961B8 (pt) | uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
NO20014662L (no) | Fremgangsmåter og preparater for behandling av faste tumorer | |
PT1053746E (pt) | Utilizacao de micro-esferas biodegradaveis libertando um agente anticanceroso para o tratamento do glioblastoma | |
BR0112311A (pt) | Compostos e composições para liberar agentes ativos, forma de dosagem unitária, método para preparar ditas composições e seu uso | |
PA8498701A1 (es) | Pirimidina-2,4,6-trionas inhibidores de metaloproteinasas | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
CY1106943T1 (el) | Υποδορια εμφυτευματα τα οποια εμφανιζουν περιορισμενη αρχικη αποδεσμευση του ενεργου συστατικου και ακολουθως γραμμικα μεταβαλλομενη εκτεταμενη αποδεσμευση | |
CL2003002277A1 (es) | Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente. | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
AR032912A1 (es) | Formulacion farmaceutica | |
AR032036A1 (es) | Tratamiento de tumores inoperables por medio de inyeccion estereotactica de microesferas | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
ATE486583T1 (de) | Pharmazeutische zusammensetzung enthaltend anastrozol | |
HRPK20030734B3 (en) | A combination comprising combretastatin and anticancer agents | |
DE60143363D1 (de) | Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern | |
BRPI0406858A (pt) | Liberação controlada de agentes altamente solúveis | |
ATE454136T1 (de) | Therapeutische zusammensetzungen zur pulmonalen verabreichung | |
ATE399532T1 (de) | Medizinische seife |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |